- Home
- BANC vs OCUL Comparison
BANC vs OCUL Comparison
Compare BANC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANC | OCUL |
|---|---|---|
| Founded | 1941 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BANC | OCUL |
|---|---|---|
| Price | $20.46 | $11.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $20.06 | ★ $22.56 |
| AVG Volume (30 Days) | 1.7M | ★ 3.1M |
| Earning Date | 01-23-2026 | 11-04-2025 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $1,019,965,000.00 | $55,783,000.00 |
| Revenue This Year | $6.10 | N/A |
| Revenue Next Year | $10.89 | $11.96 |
| P/E Ratio | $19.55 | ★ N/A |
| Revenue Growth | ★ 147.22 | N/A |
| 52 Week Low | $11.52 | $5.79 |
| 52 Week High | $20.30 | $16.44 |
Technical Indicators
Market Signals| Indicator | BANC | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 71.45 | 38.41 |
| Support Level | $19.11 | $10.92 |
| Resistance Level | $19.77 | $13.06 |
| Average True Range (ATR) | 0.41 | 0.51 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 87.58 | 17.47 |
Price Performance
Historical ComparisonAbout BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.